|
|
ABCD NATIONWIDE LIRAGLUTIDE AUDIT |
|
Papers, abstracts,
presentations, posters and webcasts emanating from the audit |
|
|
|
Webcast |
Webcast of former ABCD liraglutide and
exenatide audits research fellow, Dr Ken Thong, presenting his paper at the
IDF in Dubai, December 6, 2011:
Differences in response between exenatide and liraglutide in the Association
of British Clinical Diabetologists (ABCD) nationwide audits |
|
|
|
Published papers |
|
Bob Ryder and Ken Thong, on behalf of the ABCD
nationwide exenatide and nationwide liraglutide audit contributors. Findings
from the Association of British Clinical Diabetologists (ABCD) nationwide
exenatide and liraglutide audits. |
|
In Hot topics in diabetes, 5th edition, Vora J, ed. Synergy, London, 2012:
49-61 |
|
|
All contributors are listed |
|
|
|
K.Y. Thong, M.L. Cull, R.E.J. Ryder, C.
Walton, on behalf of the ABCD nationwide exenatide and liraglutide audit
contributors. Insulin avoidance and treatment outcomes among patients with a
professional driving licence starting glucagon-like peptide 1 (GLP-1)
agonists in the Association of British Clinical Diabetologists (ABCD)
nationwide exenatide and liraglutide audits. |
Diabetic Medicine 2012; 29(5): 690-692
Full paper (ABCD members and audit contributors only):
Diabetic Medicine 2012; 29(5): 690-692
|
All contributors are listed
|
|
|
|
K.Y. Thong, C. Walton, R.E.J. Ryder, on
behalf of the ABCD nationwide liraglutide audit contributors. Safety and
efficacy of liraglutide 1.2mg in patients with mild and moderate renal
impairment:the ABCD nationwide liraglutide audit. |
Practical Diabetes 2013; 30(2): 71-76
Full paper (ABCD members and audit contributors only):
Practical Diabetes 2013; 30(2): 71-76
|
All contributors are listed
|
|
|
|
REJ Ryder, KY Thong, AD Blann, SM Phillips, ND
Barwell, CJG Kelly, C Semple, ML Cull, P Sen Gupta for the ABCD nationwide
liraglutide audit contributors. Liraglutide pancreatitis: The ABCD
nationwide liraglutide audit. |
Br J Diabetes
Vasc Dis 2013; 13: 253-259
Full paper:
Br J Diabetes Vasc Dis 2013; 13: 253-259 |
All contributors are listed
|
|
|
|
R. E. J. Ryder, P. Sen Gupta, K. Y. Thong on
behalf of the ABCD nationwide exenatide and liraglutide audit contributors.
The Association of British Clinical Diabetologists nationwide exenatide and
liraglutide audits suggest a low incidence of acute pancreatitis. Response
to Robson. Incretins and pancreatitis—what happens next? A personal
viewpoint |
Diabetic Medicine 2013; 30(12): 1510-1511
Full paper (ABCD members and audit contributors only):
Diabetic Medicine 2013; 30(12): 1510-1511
|
All contributors are listed
|
|
|
|
KY Thong, P Sen Gupta, ML Cull, KA Adamson, DS
Dove, SV Rowles, S Tarpey, C Duncan, J Chalmers, R Harper, P McDonald, U
Brennan, C Walton, REJ Ryder on behalf of the ABCD nationwide exenatide and liraglutide
audit contributors. NICE guidelines versus clinical practice – GLP-1
receptor agonists in type 2 diabetes |
Br J Diabetes 2014; 14: 52-59
Full paper:
Br J Diabetes 2014; 14: 52-59 |
All contributors are listed
|
|
|
|
K.Y. Thong, P Sen Gupta, A.D. Blann, R.E.J.
Ryder on behalf of the ABCD nationwide liraglutide audit contributors.
The influence of age and metformin treatment status on reported
gastrointestinal side effects with liraglutide treatment in type 2 diabetes |
Diabetes Research and Clinical Practice 2015, 109: 124-129
Full paper (ABCD members and audit contributors only):
Diabetes Research and Clinical Practice 2015, 109: 124-129 |
All contributors are listed
|
|
|
|
K.Y. Thong, B.M. Mcgowan, T. Htay, A. Pernet,
C. Kelly, C. Rajeswaran, J. Howell, C. Duncan, B. Inkster, L. Buchanan, S.
Kassim, R. Nayer, N.D. Barwell, C. Walton, R.E.J Ryder, ABCD Nationwide
Liraglutide Audit contributors. Insulin treatment and longer diabetes
duration both predict poorer glycaemic response to liraglutide treatment in
type 2 diabetes: the Association of British Clinical Diabetologists
Nationwide Liraglutide Audit. |
Br J Diabetes 2015; 15(4):
169-172
Full paper:
Br J Diabetes 2015; 15(4):
169-172 |
All contributors are listed
|
|
|
|
Thomas SJ Crabtree, Susannah Rowles, Stephanie
Tarpey, Adele Kennedy, John Chalmers, Rahul Nayar, Amanda Lee, Ken Darzy,
Peter Winocour, John Lindsay, Iskandar Idris, Ken Y Thong, Piya Sen Gupta,
Amar Puttanna, Pranav Kumar, Robert EJ Ryder, On behalf of ABCD Nationwide
Audit Contributors Reductions in alanine aminotransferase levels with
liraglutide treatment are greatest in those with raised baseline levels and
are independent of weight loss: real-world outcome data from the ABCD
Nationwide Liraglutide Audit. |
BJD 2019,
Vol 19, No 2, 227
Full Paper
BJD 2019, Vol 19, No 2, 118-124 |
All contributors are listed |
|
|
|
Slides from presentations
(members and audit contributors only) |
|
DUK
Annual Professional Conference, London,
April 1, 2011 |
|
ADA Scientific Update
Satellite Meeting, San Diego, June 26 2011 |
|
ADS/ADEA Annual
Scientific Meeting, Perth, August 31, 2011 |
|
EASD Scientific Update
Satellite Meeting, Lisbon, September 14 2011 |
|
IDF Scientific Update
Satellite Meeting, Dubai, December 6 2011 |
|
IDF Main Meeting,
Dubai, December 6 2011 |
|
DUK
Annual Professional Conference,
Manchester, March 13, 2013 |
|
|
|
Abstracts |
|
Australian Diabetes
Society 2011: Ken Y Thong and Bob Ryder on behalf of the ABCD nationwide
exenatide and liraglutide audits contributors. Response of HbA1c and weight
against time in the Association of British Clinical Diabetologists (ABCD)
nationwide exenatide and liraglutide audits. 2011 ADS/ADEA Annual Scientific
Meeting Programme, Abstract 062 |
EASD Lisbon
2011: R.E.J. Ryder, K.Y. Thong, M.L. Cull, A.P. Mills, C. Walton, ABCD
nationwide
exenatide and liraglutide audit contributors. The Association of British
Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits. Diabetologia 2011, Vol.54 Supplement1:
S326 |
EASD Lisbon
2011: C. Walton, R.E.J. Ryder, M.L. Cull, A.P. Mills, K.Y. Thong, ABCD
nationwide
exenatide and liraglutide audit contributors. Factors associated with HbA1c
and weight changes at 6 months in theAssociation of British Clinical
Diabetologists (ABCD) nationwide exenatide and liraglutide audits. Diabetologia 2011, Vol.54 Supplement1:
S326 |
|
ABCD Autumn Meeting, London, 2011: CE Walton, REJ Ryder, ML Cull, AP
Mills, KY Thong, , on behalf othe ABCD nationwide exenatide and liraglutide
audit contributors. Factors associated with HbA1c and weight changes at 6
months in Association of British Clinical Diabetologists (ABCD) nationwide
exenatide and liraglutide audit. Poster 4a, ABCD Autumn Meeting 2011 |
|
ABCD Autumn Meeting, London, 2011: REJ Ryder, KY Thong, ML Cull, A P
Mills C Walton. The Association of British Clinical Diabetologists (ABCD)
nationwide exenatide and liraglutide audits. Poster 4b, ABCD Autumn Meeting
2011 |
IDF
Dubai 2011: R.E.J. Ryder, K.Y. Thong, M.L. Cull, A.P. Mills, C. Walton,
ABCD nationwide exenatide and liraglutide audit contributors. Differences in
response between exenatide and liraglutide in the Association of British
Clinical Diabetologists (ABCD) nationwide audits
Abstract Book, 21st World Diabetes Congress, IDF, Dubai, UAE, 4-8 December
2011. (oral presentation) |
IDF
Dubai 2011: K. Thong, K. Darzy, M.L. Cull, A.P. Mills, R.E.J. Ryder,
ABCD nationwide
exenatide and liraglutide audit contributors. Switching exenatide or
gliptins to liraglutide in the Association of British Clinical
Diabetologists (ABCD) nationwide liraglutide audit
Abstract Book, 21st World Diabetes Congress, IDF, Dubai, UAE, 4-8 December
2011. (poster presentation) |
IDF
Dubai 2011: K. Thong, R.E.J. Ryder, C. Walton, ABCD nationwide exenatide
and liraglutide audit contributors. Factors associated with HbA1c and weight
changes in the Association of British Clinical Diabetologists nationwide
GLP-1 agonists audits.
Abstract Book, 21st World Diabetes Congress, IDF, Dubai, UAE, 4-8 December
2011. (poster presentation) |
|
ADA Philadelphia 2012: KEN Y. THONG, CHRISTOPHER WALTON, ROBERT EJ.
RYDER, ABCD NATIONWIDE LIRAGLUTIDE AUDIT CONTRIBUTORS. Insulin Necessity is
Better than Diabetes Duration in Predicting Liraglutide Treatment Response:
The Association of British Clinical Diabetologists (ABCD) Nationwide
Liraglutide Audit. Diabetes 2012; 61 (Suppl. 1): 1038P |
|
ADA Philadelphia 2012: KEN Y. THONG, CHRISTOPHER WALTON, ROBERT EJ.
RYDER, ABCD NATIONWIDE LIRAGLUTIDE AUDIT CONTRIBUTORS. Liraglutide is Safe
and Effective in Mild or Moderate Renal Impairment: The Association of
British Clinical Diabetologists (ABCD) Nationwide Liraglutide Audit.
Diabetes 2012; 61 (Suppl. 1): 1113-P |
|
EASD Berlin
2012: R.E.J. Ryder, P. Sen-Gupta, K.Y. Thong, ABCD nationwide
liraglutide audit contributors. Liraglutide is effective across a range of
obese body mass indices; findings from the Association of British Clinical
Diabetologists (ABCD) nationwide liraglutide audit. Diabetologia 2012, Vol.55 Supplement1:
S330 |
|
DUK
Manchester 2013; Diabetes Research Award Session. Sen Gupta P, Thong KY,
Cull M, Winocour P, Ryder REJ on behalf of the ABCD nationwide liraglutide
audit contributors. Does liraglutide therapy affect the metabolic response
in patients with elevated alanine aminotransferase and Type 2 Diabetes?: the
Association of British Clinical Diabetologists (ABCD) nationwide liraglutide
audit. Diabetic Medicine 2013. 30 (Suppl 1): 3. |
|
ABCD
Spring Meeting, Solihull, 2013, abstract 1: P Sen Gupta, KY Thong, REJ Ryder, on behalf of the ABCD nationwide liraglutide
audit contributors. Combined insulin and liraglutide therapy is associated
with metabolic improvement and reduction in insulin dose in commonly
prescribed insulin regimens: an ABCD liraglutide audit analysis. Poster 1, ABCD
Spring Meeting 2013 |
|
ABCD
Spring Meeting, Solihull, 2013, abstract 15: REJ Ryder, KY Thong,
A Blann, S Phillips, N Barwell, C Kelly, C Semple, S Struthers, P Sen Gupta, on behalf of the ABCD nationwide liraglutide
audit contributors. Liraglutide and acute pancreatitis in the Association of
British Clinical Diabetologists (ABCD) nationwide liraglutide audit. Poster
15 (late breaking), ABCD Spring Meeting 2013 |
|
ADA
Chicago 2013: PIYA SEN GUPTA, KEN Y THONG, MATTHEW ARMSTRONG, PHILIP N.
NEWSOME, PETER WINOCOUR, REJ RYDER, ABCD NATIONWIDE LIRAGLUTIDE AUDIT
CONTRIBUTORS. Does Liraglutide Therapy Affect the Metabolic Response in
Patients with Elevated Alanine Aminotransferase and Type 2 Diabetes
Mellitus?: The ABCD Nationwide Liraglutide Audit.
Diabetes 2013; 62 (Suppl. 1): 1037P |
|
IDF
Melbourne 2013: K.Y. Thong, P. Sen Gupta, R.E.J. Ryder, ABCD nationwide exenatide
and liraglutide audit contributors. The efficacy of exenatide and
liraglutide among South Asians in the Association of British Clinical
Diabetologists nationwide audits.
Abstract Book, 22nd World Diabetes Congress, IDF, Melbourne, Australia, 2-6 December
2013. (poster presentation) |
|
ABCD
Spring Meeting, Edinburgh, 2014, abstract 1: KY Thong, P Sen
Gupta, ML Cull, KA Adamson, DS Dove, SV Rowles, S Tarpey, C Duncan, J
Chalmers, R Harper, P McDonald, U Brennan, C Walton, REJ Ryder on behalf of the ABCD nationwide
exenatide and liraglutide
audit contributors. NICE guidelines versus clinical practice – GLP-1
receptor agonists in type 2 diabetes: the ABCD nationwide audits. Poster 1, ABCD Spring Meeting 2014 |
|
ADA
San Francisco 2014: P Sen Gupta, KY Thong, C Walton, REJ Ryder on behalf
of the ABCD nationwide liraglutide audit contributors. Combined
Liraglutide-Insulin Therapy Is Associated with Metabolic Improvement and
Insulin Dose Reduction in Commonly Prescribed Insulin Regimens.
Diabetes 2014; 63 (Suppl. 1): 1023-P |
|
EASD Berlin 2018: C. Walton, S. Kassim, R. Harper, P. McDonald, U.
Brennan, J. Harding, T. Htay, R. Nayar, A.Pernet, S. Rowles, K. Adamson,
K.Y. Thong, R.E.J. Ryder, ABCD nationwide liraglutide audit contributors.
Early impact of liraglutide in routine clinical use (ABCD nationwide
liraglutide audit) on cardiovascular risk (UKPDS risk engine) |
|
|
|
Posters (members and audit contributors
only) |
|
EASD Lisbon 2011a |
|
EASD Lisbon 2011b |
|
ABCD London
Autumn 2011a |
|
ABCD London Autumn 2011b |
|
IDF
Dubai 2011a |
|
IDF
Dubai 2011b |
|
ADA Philadelphia 2012a |
|
ADA Philadelphia 2012b |
|
EASD Berlin 2012 |
|
DUK Manchester 2013 |
|
ABCD
Solihull Spring 2013a |
|
ABCD
Solihull Spring 2013b |
|
ADA Chicago 2013 |
|
IDF
Melbourne 2013 |
|
ABCD
Edinburgh Spring 2014 |
|
ADA San Francisco 2014 |
|
EASD
Berlin 2018 |
|
|
|
The ABCD nationwide liraglutide audit is an independent audit supported by an
unrestricted grant from Novo Nordisk Ltd |
|
